Comparative Study of Monoclonal and Recombinant Antibody-Based Immunoassays for Fungicide Analysis in Fruit juices by Moreno Tamarit, Mª José et al.
 Document downloaded from: 
 
This paper must be cited as:  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The final publication is available at 
 
 
Copyright 
http://dx.doi.org/10.1007/s12161-013-9655-z
http://hdl.handle.net/10251/43166
Springer Verlag (Germany)
Moreno Tamarit, MJ.; Plana Andani, E.; Manclus Ciscar, JJ.; Montoya Baides, Á. (2014).
Comparative Study of Monoclonal and Recombinant Antibody-Based Immunoassays for
Fungicide Analysis in Fruit juices. Food Analytical Methods. 7(2):481-489.
doi:10.1007/s12161-013-9655-z.
Food Analytical Methods
 
Comparative study of monoclonal and recombinant antibody-based immunoassays for
fungicide analysis in fruit juices
----
 
Manuscript Number: FANM-D-13-00065R3
Full Title: Comparative study of monoclonal and recombinant antibody-based immunoassays for
fungicide analysis in fruit juices
Article Type: Original Research
Keywords: fungicide residues;  monoclonal antibodies;  recombinant antibodies;  immunoanalysis;
ELISA;  fruit juices
Corresponding Author: Angel Montoya, PhD
Universitat Politècnica de València
Valencia, Valencia SPAIN
Corresponding Author Secondary
Information:
Corresponding Author's Institution: Universitat Politècnica de València
Corresponding Author's Secondary
Institution:
First Author: María-José Moreno
First Author Secondary Information:
Order of Authors: María-José Moreno
Emma Plana
Juan J. Manclús, PhD
Angel Montoya, PhD
Order of Authors Secondary Information:
Abstract: A comparative study of the analytical performance of enzyme-linked immunosorbent
assays (ELISAs), based on monoclonal and recombinant antibodies, for the
determination of fungicide residues in fruit juices has been carried out. To this aim,
three murine hybridoma cell lines secreting specific monoclonal antibodies against
tetraconazole, thiabendazole, and imazalil were used as a source of immunoglobulin
gene fragments for the production of single-chain variable fragment (scFv) and fusion
scFv-pIII recombinant antibodies in Escherichia coli. Selected recombinant antibodies
displayed cross-reactivity profiles very similar to those of the parent monoclonal
antibodies. Imazalil and tetraconazole recombinant antibodies showed one order of
magnitude lower affinity than their respective monoclonal antibodies, whereas the
thiabendazole recombinant antibodies showed an affinity similar to that of their parent
monoclonal antibody. On the other hand, scFv-pIII fusion fragments showed similar
analytical properties as, and occasionally better than, scFv recombinant antibodies.
Finally, ELISAs developed from each antibody type showed similar analytical
performance when applied to the analysis of the target fungicides in fruit juices.
Powered by Editorial Manager® and Preprint Manager® from Aries Systems Corporation
 1 
Comparative study of monoclonal and recombinant antibody-based 
immunoassays for fungicide analysis in fruit juices   
 
Running head: Comparative immunoanalysis of fungicides in juices 
 
María-José Moreno, Emma Plana, Juan J. Manclús and Angel Montoya

 
Instituto Interuniversitario de Investigación en Bioingeniería y Tecnología Orientada al Ser 
Humano, Universitat Politècnica de València 
Camino de Vera s/n Edificio 8B-N, 2ª planta 
 46022 Valencia, Spain 
 

Author to whom correspondence should be addressed (telephone +34-96-3877093; fax: +34-
96-3877093; e-mail: amontoya@ginmuno.i3bh.es 
*Manuscript
Click here to download Manuscript: Moreno-text rev3.doc 
Click here to view linked References
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 2 
Abstract 
A comparative study of the analytical performance of enzyme-linked immunosorbent assays 
(ELISAs), based on monoclonal and recombinant antibodies, for the determination of 
fungicide residues in fruit juices has been carried out. To this aim, three murine hybridoma 
cell lines secreting specific monoclonal antibodies against tetraconazole, thiabendazole, and 
imazalil were used as a source of immunoglobulin gene fragments for the production of 
single-chain variable fragment (scFv) and fusion scFv-pIII recombinant antibodies in 
Escherichia coli. Selected recombinant antibodies displayed cross-reactivity profiles very 
similar to those of the parent monoclonal antibodies. Imazalil and tetraconazole recombinant 
antibodies showed one order of magnitude lower affinity than their respective monoclonal 
antibodies, whereas the thiabendazole recombinant antibodies showed an affinity similar to 
that of their parent monoclonal antibody. On the other hand, scFv-pIII fusion fragments 
showed similar analytical properties as, and occasionally better than, scFv recombinant 
antibodies. Finally, ELISAs developed from each antibody type showed similar analytical 
performance when applied to the analysis of the target fungicides in fruit juices. 
  
Keywords: fungicide residues; monoclonal antibodies; recombinant antibodies; 
immunoanalysis; ELISA; fruit juices 
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Introduction 
 
Imazalil [(RS)-1-(β-allyloxy-2,4-dichlorophenylethyl)imidazole], tetraconazole [(RS)-2-
(2,4-dichlorophenyl)-3-(1H-1,2,4-triazol-1-yl)propyl-1,1,2,2-tetrafluoroethyl ether], and 
thiabendazole [2-(4-triazolyl)benzimidazole] are broad spectrum antimicrobial 
compounds widely used as fungicides in the post harvest treatment of fruit and 
vegetables. Because of their application, residues of these fungicides can remain in 
agricultural products and, obviously, in their derivatives. This fact claims the 
establishment of legal directives worldwide to control their levels through the 
Maximum Residue Limits (MRLs). To guarantee consumer protection in the EU, MRLs 
have been harmonized by the European Commission in the Regulation No. 396/2005. 
According to this regulation, tetraconazole, imazalil, and thiabendazole levels up to 0.5, 
5, and 15 mg/kg
 
have been fixed, respectively, in fresh fruit and in their derivatives (EU 
Pesticide Database 2013). Therefore, appropriate analytical methods for an efficient 
monitoring of these fungicide residues in food are required. 
Nowadays, liquid chromatography coupled with single or tandem mass 
spectrometry is the most common analytical methodology for these fungicides (Ferrer et 
al. 2011; Hiemstra and de Kok 2007; Yoshioka et al. 2010). These chromatographic 
methods require sophisticated and high-cost equipment only available in centralized, 
well-equipped laboratories. Immunochemical techniques, mainly enzyme-linked 
immunosorbent assays (ELISA), are alternative or complementary analytical tools to 
conventional methods. These techniques are simple, cost-effective, and field-portable; 
moreover, they do not require sophisticated instrumentation, and are able to analyze a 
large number of samples (Morozova et al. 2005). 
Antibodies have been used during the last decades as immunoanalytical tools for 
the detection of low molecular weight contaminants in food and the environment. 
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Polyclonal antibodies are easy to obtain but their heterogeneity and limited supply can 
be a serious drawback for method standardization. The advent of hybridoma technology 
allowed to produce monoclonal antibodies (MAbs) of invariant specificity and 
selectivity and to immortalize the cells that produce these antibodies. However, MAb 
production is expensive, time-consuming, and considered as a rather inefficient 
procedure. As a third alternative, recombinant technology can be used to generate 
antibody fragments, as immunoanalytical tools for small analytes, in a more cost-
effective and efficient manner than using the hybridoma technology; furthermore, the 
use of animals for antibody production can be minimized and eventually eliminated. 
Moreover, recombinant antibody (RAb) properties can be tailored at convenience by a 
range of DNA mutagenesis and protein engineering techniques (Brichta et al. 2005; 
Kramer and Hock 2007; Markus et al. 2011; Sheedy et al. 2007).
 
Recombinant antibody fragments can be isolated from display libraries using in 
vitro selection technologies that essentially mimic the in vivo process. The most 
frequently used are: phage display, ribosome display, or cell surface display in bacteria 
or yeast systems (Sheedy et al. 2007). Particularly, the advent of phage display 
technology, which allows the rapid and efficient isolation of RAbs from libraries of 
antibody fragments displayed on the surface of filamentous bacteriophages, was 
decisive in this evolution (Brichta et al. 2005). In the last decades, a large number of 
RAbs against high molecular weight molecules have been obtained to be used as 
diagnostic or therapeutic tools in health sciences and related areas. More recently, RAb 
technology has expanded to other applications such as the immunochemical analysis of 
low molecular weight compounds. Particularly, the production of RAbs to 
agrochemicals such as paraquat (Graham et al. 1995), diuron (Scholthof et al. 1997), 
parathion (Garret et al. 1997), cyclohexanedione (Webb et al. 1997), picloram (Yau et 
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al. 1998), chlorpyrifos (Alcocer et al. 2000), atrazine (Charlton et al. 2001), malathion 
(Nishi et al. 2003), 2,4−dichlorophenoxyacetic acid (Brichta et al. 2003), simetryn 
(Nishi et al. 2005), and methamidophos (Li et al. 2006) has been described. Initially, 
hapten-specific RAbs were obtained from hybridoma cells; subsequently, immunized 
lymphocytes were the source of genetic material to construct immune phage-display 
antibody libraries from which hapten-specific RAbs have been selected (Brichta et al. 
2005; Markus et al. 2011). Lately, hapten-specific RAbs have also been isolated from 
non-immune or even synthetic libraries (Brichta et al. 2003; Kramer and Hock 2007; 
Markus et al. 2011). The most usual recombinant antibody fragment was the single 
chain variable fragment (scFv), where the VH and VL chains are single-domain linked 
by a 15 amino acids long polypeptide linker (Brichta et al. 2005). Expression of scFvs 
fused to proteins of interest has also been described. Different fusion protein partners 
have been evaluated to increase scFv solubility and stability, and to improve the 
detection, purification or immobilization of scFv (Leong and Chen 2008).
 
Thus, short 
peptides as c-myc, poly-histidine, FLAG or HSV and larger polypeptides as the 
truncated pIII protein of phage M13 or alkaline phosphatase have been used for 
detection and purification; on the other hand, engineered single-amino acid residues 
have been introduced for site-specific chemical coupling of RAbs (Alcocer et al. 2000; 
Krebber et al. 1997; Markus et al. 2011; Nishi et al. 2005).  
In the last decades, numerous studies on the application of MAb-based 
immunoassays for the determination of agrochemical residues in food and 
environmental samples have been reported (Morozova et al. 2005). As previously 
argued, advances in RAb production and selection, the introduction at convenience of 
functional molecules for detection or immobilization, and the possibility of modifying 
RAb properties afford a powerful technology to obtain tailor-made binders for 
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analytical purposes in food (Markus et al. 2011). However, few studies dealing with the 
application of recombinant-based immunoassays to the analysis of agrochemicals in 
food and environmental samples have been reported to date (Alcocer et al. 2000; Nishi 
et al. 2005). Consequently, understanding the potential, limitations and opportunities of 
RAbs in food analysis as compared to conventional antibodies is an important issue to 
find out the future role of RAbs as immunochemical tools.  
The aim of this work was to carry out a comparative study of the analytical 
performance of immunoassays, based on MAbs and on their derived RAbs, to imazalil, 
tetraconazole, and thiabendazole. To this aim, each RAb was cloned from their 
respective hybridoma cell line and expressed in E. coli. Apart from scFv, scFv-pIII 
antibody fragments were assayed because these fusion fragments may offer production, 
detection and purification advantages. Finally, a comparison of the analytical properties 
of the ELISAs developed with monoclonal and recombinant antibodies in the analysis 
of fruit juices spiked with the target fungicides was performed. 
 
Materials and Methods 
 
Reagents and Instruments  
 
Analytical standards of tetraconazole and 2-(2,4-Dichlorophenyl)-3-(1H-1,2,4-triazol-1-
yl)propanol (DTP) were from Isagro Ricerca (Galliera, Italy). Hexaconazole standard 
was from Syngenta (Bracknell, UK). All of the other fungicide standards were from 
Riedel-de Haën (Sigma-Aldrich S.A., Madrid, Spain). Ovalbumin (OVA), o-
phenylenediamine (OPD), cloramphenicol, kanamycin, tetracycline, nalidixic acid, 
isopropyl-β-thiogalactopyranoside (IPTG), and 10× Blocking Buffer (BB) were also 
obtained from Sigma. Peroxidase-labelled rabbit anti-mouse immunoglobulins were 
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 7 
obtained from Dako (Glostrup, Denmark). Restriction endonuclease SfiI was purchased 
from Roche Diagnostics (Sant Cugat del Vallés, Spain). T4 DNA ligase was from 
Fermentas (Madrid, Spain). Taq DNA polymerase MasterMix was purchased from 
Eppendorf (Hamburg, Germany). E. coli XL1-Blue (recA1 endA1 gyrA96 thi-1 hsdR17 
glnV44 relA1 lac / F' Tn10 (Tet
r
) proA
+
B
+
 lacl
q
 Δ(lacZ)M15) was from Stratagene 
(Cedar Creek, TX) and E. coli HB2151 (K12, ara Δ(lac-pro) thi / F’ proA+B+ 
Δ(lacZ)M15) was from Maxim Biotech (South San Francisco, CA). M13KO7 helper 
phage was purchased from GE Healthcare (Barcelona, Spain). 2×YT medium and 
agarose for DNA electrophoresis were from Conda Laboratories (Madrid, Spain). 
Primers were purchased from Integrated DNA Technologies (IDT, Coraville, IA). 9E10 
anti-myc hybridoma cell line was from American Tissue Type Culture Collection 
(Rockville, MD). The pAK100 phagemid was kindly provided by Dr. A. Plückthun 
(Inst. Biochemistry, University of Zürich, Switzerland). This phagemid allows the 
expression of a myc tag between the scFv fragment and the truncated pIII protein 
(Krebber et al. 1997).             
Polymerase chain reactions were carried out in the Mastercycler gradient thermal 
cycler from Eppendorf. Flat bottom polystyrene ELISA plates (High Binding Plates) 
were from Costar (Cambridge, MA). ELISA plates were washed with a 96 PW 
microplate washer from SLT Labinstruments GmbH (Salzburg, Austria).  Absorbance 
was read in dual-wavelength mode (490-650 nm) with an Emax microplate reader from 
Molecular Devices (Sunnyvale, CA). mRNA concentrations were determined by an 
UV-160A Shimadzu spectrophotometer (Kyoto, Japan). 
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Cloning of scFv Antibody Fragments 
  
Messenger RNA isolation and first-strand cDNA synthesis. The production of the parent 
monoclonal antibodies TN3C-33, IMH-51, and DTPH-41 (raised against thiabendazole, 
imazalil, and tetraconazole, respectively) has been previously described (Abad et al. 
2001; Manclús et al. 2008; Moreno et al. 2007). For each hybridoma, 5×10
6 
cells were 
pelleted by centrifugation at 780g for 5 min and resuspended in 400 µl of mRNA 
extraction buffer. mRNA was isolated and purified using the QuickPrep Micro mRNA 
kit from GE Healthcare. Purified mRNA was precipitated with ethanol, washed and air-
dried. The pellet was resuspended in 50 µl of molecular biology grade water. mRNA 
purity and concentration were determined by UV spectrophotometry. Next, 0.1 µg of 
mRNA served as the template for first-strand cDNA synthesis using the corresponding 
kit from GE Healthcare. 
 
 Amplification of immunoglobulin variable regions by PCR. cDNA was used as PCR 
template for the amplification of VL and VH domains using the oligonucleotide primers 
described by Krebber et al. (1997). These primers are complementary to the 5' and 3' 
coding sequences of each murine immunoglobulin variable regions, and encode 
additional sequences for restriction endonucleases and the linker sequence. VL primers 
were selected according to the MAb IgG isotype. PCR was carried out under the 
following conditions: after 3 min denaturation at 92 ºC, Taq DNA polymerase was 
added, followed by 5 cycles of 1 min at 92 ºC, 1 min at 50 ºC, 1 min at 72 ºC, and 20 
cycles of 1 min at 92 ºC, 1 min at 63 ºC, 1 min at 72 ºC. The PCR amplified DNA 
products were concentrated by Microcon YM30 filter devices from Millipore (Bedford, 
MA), purified by preparative agarose gel electrophoresis using the MinElute gel 
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 9 
extraction kit from Qiagen (Izasa,Barcelona, Spain), and quantified by analytical gel 
electrophoresis using DNA molecular weight markers from Fermentas. 
 
Assembly of scFv antibody fragments. Assembly reactions were performed as described 
by Krebber et al. (1997) with few modifications for imazalil scFv fragments. Briefly, 
reactions contained equimolecular amounts (10 ng) of VH and VL DNA, scfor and 
scback primers, and the Eppendorf MasterMix (2.5×) containing the Taq DNA 
polymerase and an appropriate mixture of dNTPs. VL and VH products were first 
assembled into the scFv format by splicing by overlap extension PCR and subsequently 
scFv was amplified by the scback and scfor primer set. Assembled scFv fragments were 
purified as above. 
The scFv DNA and the phage display vector pAK100 were digested with SfiI, 
purified and ligated. The ligation product was transformed into electrocompetent E. Coli 
XL1-Blue cells. Transformed cells were plated onto 2×YT solid agar medium 
containing 1 % (w/v) D-glucose and 25 µg/ml chloramphenicol (2×YT-GC) and grown 
overnight at 37 ºC. 
 
Screening of scFv Colonies 
 
Single chloramphenicol-resistant colonies were picked into 96 × 2.2 ml tube plates 
(Eppendorf) containing 2×YT-CG medium (400 µl) and incubated overnight at 30 ºC 
with orbital shaking at 250 rpm. Forty µl of overnight culture was added to 400 µl of 
2×YT-GC medium and incubated until the culture reached an optical density at 550 nm 
(OD550) of 0.4. Cells were pelleted by centrifugation at 1000g for 5 min at room 
temperature and resuspended in 400 µl of 2×YT-C (no glucose) containing 1mM IPTG. 
The incubation was continued for 20 h. Finally, 100 µl of phosphate-buffered saline 
(PBS, 10 mM phosphate, 0.15 M NaCl, pH 7.5) containing 0.5 % Tween 20 was added 
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to each well and plates were centrifuged at 1000g for 10 min. Supernatants were then 
checked for the presence of scFv-pIII fusion proteins that recognized thiabendazole, 
imazalil, or tetraconazole. The screening consisted of the simultaneous performance of a 
non-competitive (in the absence of analyte) and a competitive (in the presence of 
analyte) indirect ELISA. Immunoassay conditions are described in the fungicide 
immunoassay procedure. 
ScFv production was accomplished by transforming HB2151 cells (E. Coli non-
suppressor strain) with plasmids containing the specific scFv insert. Previously, these 
plasmids were extracted and purified from positive E. Coli XL1-Blue cells with the 
Perfectprep Plasmid Mini kit purchased from Eppendorf. Transformed cells were plated 
onto 2×YT-GC solid agar medium containing 25 µg/ml of nalidixic acid. Several 
nalidixic acid-resistant colonies were picked into 96 × 2.2 ml tube plates containing 
2×YT-GC medium (400 µl) to produce scFv as described above. Supernatants were 
checked for RAb activity with the screening ELISA. 
 
Panning of Phage Displayed scFv Antibodies 
 
Transformed XL1-Blue colonies were scraped off the agar plate into 10 ml 2×YTGC 
medium and cells were counted. To rescue scFv displaying phages, 7 ml of 2×YTCG 
medium was inoculated with 10
8
 cells and incubated at 37 ºC with shaking. When an 
OD550 of 0.5 was reached, 2.5 µl of 1M IPTG and 10
10
 cfu of M13KO7 helper phage 
were added to 5 ml of cell culture. After 15 min of infection without shaking, 5 ml of 
fresh 2xYTCG medium containing 0.5 mM IPTG was added and the incubation was 
continued for 2 h at 30 ºC with shaking. Then, 30 µg/ml of kanamycin was added and 
the phage production was carried out overnight. For phage purification, 1.1 ml of phage 
culture was centrifuged at 1000g at 4 ºC for 15 min to sediment cells. Next, 250 µl of 
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PEG/NaCl solution (2.5 M NaCl containing 20 % w/v PEG 8000, Sigma) was added to 
1 ml supernatants. After incubating for 30 min at 4 ºC, precipitated phages were pelleted 
as above, resuspended in 1 ml of 2×YT medium and sequentially filtered through a 3 
and 0.45 µm filters. Finally, recombinant phages were titrated by infecting XL1-Blue 
cells. Panning was performed at room temperature as follows. The corresponding 
hapten conjugate, at 10 µg/ml (100 µl per well) in 50 nM carbonate buffer, pH 9.6, was 
passively absorbed to ELISA plates overnight at room temperature. Unbound coating 
conjugate was removed and plates were washed 3 times with 300 µl/well of 1×BB. 
Next, unoccupied sites were blocked with 200 µl/well of 1×BB for 1h. Then, phage 
preparations were diluted to 10
10
 phages/ml in 1×BB and let stand for 30 min before 
adding 100 µl per well (10
9
 phages) and incubating for 1h. After washing 5 times with 
300 µl/well of 1×BB, phages were competitively eluted by incubating for 30 min with 
100 µl per well of 100 nM analyte. Eluted phages were used to infect 100 µl of XL1-
Blue cells. Finally, infected cells were plated onto solid 2×YTGC medium and grown 
overnight at 37 ºC. Transformed colonies can be used to prepare a new recombinant 
phage population for the next panning round as required.  
 
Production of Recombinant Antibodies 
 
Small scale production of RAb fragments, both scFv and scFv-pIII, was carried out 
using the method described by Kipriyanov et al. (1997) with slight modifications. For 
each fungicide, 10 ml of 2×YTGC medium was inoculated with the corresponding XL1-
Blue or HB2151 cells containing DNA sequences encoding the scFv-pIII or scFv 
fragments, respectively, and grown overnight with shaking at 37 ºC. Two ml of 
overnight culture was added to a 2 L flask containing 100 ml of 2×YT-GC medium and 
cells were incubated at 37 ºC with shaking at 250 rpm until the culture reached an OD550 
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of 0.8. Cells were then pelleted by centrifugation at 1500g for 10 min at room 
temperature and resuspended in 100 ml of freshly prepared 2×YT-C (containing 0.4 M 
saccharose and 0.1 mM IPTG), and the incubation was continued overnight at 30 ºC. 
Cultures were centrifuged at 5000g for 10 min at 4 ºC. Next, supernatants were 
centrifuged again at 30000g for 20 min at 4 ºC rendering the initial supernatant (So). 
Pellets were resuspended in 5 ml of cool periplasmic extraction buffer (50 mM 
Tris/HCl, 1mM EDTA, and 20 % saccharose) and cooled for 1 h in an ice-water bath 
with occasional shaking. Finally, supernatants were collected by centrifugation at 
30000g for 30 min at 4 ºC to render the periplasmic supernatant (Sp). So and Sp 
supernatants were mixed and concentrated in an ultrafiltration cell (Amicon). ScFv and 
scFv-pIII fragments were confirmed by ELISA. Supernatants were concentrated and 
stored at -20ºC. RAb activity was stable throughout this study. 
Fungicide Immunoassays 
 
MAb-based ELISAs were performed using specific hapten coating conjugates as 
previously described (Abad et al. 2001; Manclús et al. 2008; Moreno et al. 2007). RAb-
based ELISAs were performed as follows. A volume of 100 µl per well was used 
throughout all assay steps, and all incubations were carried out at room temperature. 
After each incubation, plates were washed four times with washing solution (0.15 M 
NaCl containing 0.05% Tween 20). ELISA plates were coated overnight by adding the 
specific hapten conjugate in 50 mM carbonate buffer, pH 9.6. Then, 50 µl per well of 
standards or sample extracts adequately diluted in PBS were added to triplicate wells, 
followed by 50 µl per well of RAb dilution in PBS containing 0.0025% Tween 20, and 
plates were incubated for 1h. After washing, plates were incubated for 1 h with anti-myc 
MAb at 1 µg/ml in PBST (PBS containing 0.05% Tween 20). Next, plates were 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 13 
incubated for 1 h with peroxidase-labelled rabbit anti-mouse immunoglobulins diluted 
1/2000 in PBST. Finally, peroxidase activity bound to the wells was determined by 
adding the substrate solution (2 mg/ml OPD and 0.012% H2O2 in 25 mM citrate and 62 
mM sodium phosphate, pH 5.35). After 10 min, the reaction was stopped with 2.5 M 
sulphuric acid and the absorbance at 490 nm was read and recorded. 
 
Preparation of Standards and Samples 
 
Analyte stock solutions in the appropriate range for each immunoassay were prepared 
by serial dilution in N,N-dimethylformamide (DMF) and stored at -20 ºC. From these 
stock solutions, working standards were daily prepared by 1/500 dilution in PBS. 
Orange and apple juices were obtained from a local supermarket. Twenty five ml of 
fruit juice samples were spiked with thiabendazole at 50, 100, and 1000 ng/ml by 
adding 25 µl of 50, 100, or 1000 µg/ml thiabendazole stock solutions in DMF, 
respectively. For imazalil or tetraconazole, juice samples were spiked at 1000, 2000, 
and 5000 ng/ml by adding 25 µl of 1000, 2000, or 5000 µg/ml fungicide stock solutions 
in DMF, respectively. For ELISA determinations, spiked juice samples were 
appropriately diluted in PBS and analyzed without any further treatment. Each dilution 
was analyzed in triplicate and the fungicide concentration in samples was calculated by 
averaging the values obtained at each dilution. 
 
Results and Discussion 
 
Hybridoma cell lines secreting MAbs against fungicides were used as a source of 
immunoglobulin genes. RAbs were expressed in E. coli as single chain variable 
fragments (scFv) in a non-suppressor strain, and as fusion proteins of scFv and 
bacteriophage coat pIII truncated protein (scFv-pIII) in a suppressor strain. The major 
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advantage of the fusion protein over the other scFv format is that no additional 
transformation is required because E. coli XL1-blue is a suppressor strain. Both RAb 
fragments were produced to study their properties and analytical performance. 
  
Cloning and Expression of scFv and scFv-pIII RAb Fragments 
 
Messenger RNA was isolated from TN3C-33, IMH-51 and DTPH-41 hybridoma cell 
lines, secreting anti-thiabendazole, anti-imazalil and anti-tetraconazole MAbs, 
respectively, and then the first strand cDNA synthesis was carried out. VL and VH genes 
were selectively amplified by PCR, using the universal primer sets specific for the 
variable regions of murine immunoglobulin V genes (Krebber et al. 1997). Next, rounds 
of PCR were performed to link the VL and VH genes via a (Gly4Ser)3 encoding DNA 
linker sequence in the VL-linker-VH configuration (scFv). ScFv gene fragments were 
then cloned into the phagemid vector pAK100 and used to transform XL1-Blue cells. 
These transformations yielded populations of 1.5×10
4
 (thiabendazole), 3.5×10
3
 
(imazalil), and 3.5×10
4
 (tetraconazole) colonies. Screening of functional recombinant 
antibodies was performed by expressing individual transformed XL1-Blue colonies in 
the presence of 1 mM IPTG. As E. Coli XL1-Blue is a suppressor strain, translation 
proceeds through the amber stop codon producing the scFv-pIII fusion protein. 
Bacterial supernatants were then checked for the expression of functional fusion 
proteins. The screening consisted of the simultaneous performance of a non-competitive 
and a competitive indirect ELISA, to test the ability of antibody fragments to bind the 
corresponding OVA conjugate of the immunizing hapten and to recognize 
thiabendazole, imazalil, or tetraconazole in solution, respectively. Colony analysis was 
carried out by detection of scFv-pIII fusion proteins instead of phage-displayed scFv 
because the latter can be less efficient than the former, particularly for selecting hapten-
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specific scFv. In this sense, phage-displayed scFv analysis is a more laborious 
procedure because a phage rescue step is required. Moreover, the size and complexity of 
phage-displayed scFv may contribute to unspecific interactions that would mask the 
specific ones (Mersmann et al. 1998; Tout et al. 2001). 
By analysing a few colonies of each population, 34 of 48 and 40 of 48 tested 
colonies rendered wells with scFv-pIII antibody fragments recognizing thiabendazole 
and tetraconazole, respectively, in competitive assays. With regard to imazalil, none of 
48 tested colonies expressed scFvs recognizing this fungicide. Therefore, a round of 
panning was performed searching for functional imazalil-specific scFvs. Panning was 
performed in ELISA plate wells coated with 10 µg/ml of OVA-IMH (Moreno et al. 
2007). After the first round of panning, 6 of 96 randomly selected colonies rendered 
wells with scFv-pIII antibodies recognizing imazalil. 
Plasmids containing the specific scFv insert for thiabendazole, imazalil or 
tetraconazole from three colonies expressing scFv-pIII antibodies for each fungicide 
were used to transform non-suppressor E. coli HB5151 cells for scFv production. A few 
HB2151 clones containing the specific scFv insert for imazalil, tetraconazole, or 
thiabendazole were selected to produce scFv fragments. All assayed clones produced 
scFv antibodies that recognized the free analyte. Recombinant scFv and scFv-pIII 
fragments were detected in the culture medium and in the periplasmic space of 
transformed cells. 
 
 Characterization of scFv Recombinant Antibodies 
 
RAbs were used to develop ELISAs in the conjugate-coated format. Immunoassay 
development and optimization was performed as previously reported for monoclonal 
antibody-based ELISAs to conazoles (Manclús et al. 2008). Standard curves obtained 
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under optimum assay conditions, for each fungicide and antibody type, are depicted in 
Figure 1. Analytical parameters of the competitive curves were estimated and compared 
to those of the parent MAbs. Results are shown in Table 1. As it can be observed, 
imazalil and tetraconazole RAbs showed one order of magnitude lower affinity 
(estimated as lower I50 values, concentrations giving 50% inhibition of the maximum 
absorbance) than their respective MAbs, whereas thiabendazole RAbs showed similar 
affinity to that of their parent MAb. With regard to the studied recombinant fragments, 
both of them presented a similar behaviour except for imazalil. In this case, the 
sensitivity of the ELISA configured with the fusion fragment was higher (lower I50 
value) than that of the ELISA configured with free scFv. When affinities of RAbs and 
those of their parental MAbs have been compared in the literature, diverse results have 
been reported. While some authors reported that RAbs showed lower affinity than their 
parental MAb, others reported a comparable or even higher affinity of RAbs over their 
counterpart MAbs (Graham et al. 1995; Kramer and Hock 2007; Nishi et al. 2005; Tout 
et al. 2001). Results obtained in this study and those reported in the literature point out 
that the binding site structure of scFvs differs somehow from that of their respective 
parental antibody molecules (MAb). These differences in the scFv structure could be 
attributed to the absence of constant domains, the presence of a linker peptide, and the 
introduction of mutations derived from the use of degenerated primers to amplify 
antibody genes. To this respect, the cloning and expression of antibody genes as Fab 
recombinant fragments could mimic better the MAb structure and activity.  
The specificity of MAbs and that of their derived RAbs were evaluated by 
performing competitive assays using several structurally related compounds as 
competitors. All imazalil antibodies displayed the same reactivity pattern. 
Immunoassays were very specific for imazalil, because the assayed fungicides 
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(climbazole, hexaconazole, myclobutanil penconazole, prochloraz, propiconazole, 
tebuconazole, tetraconazole, and triadimefon) were not recognized (cross-reactivity 
<0.1 %) (Moreno et al. 2007). With regard to the specificity of thiabendazole 
antibodies, the cross-reactivity pattern of RAbs was found to be very similar to that of 
the parent monoclonal antibody (Table 2). Only chlorfenazole and fuberidazole were 
slightly recognized. On the other hand, only minor differences between the cross-
reactivity pattern of the MAb to tetraconazole and that of its derived RAbs were 
observed (Table 3). In this case, the immunoassays were not specific to tetraconazole 
because penconazole, cyproconazole, myclobutanil, and DTP (hydrolysis product of 
tetraconazole) were recognized at a significant extent: 44-90%, 32-50%, 14-33% and 
24-58%, respectively. 
 
Recovery Analysis of Spiked Juice Samples by the Developed ELISAs 
 
The analytical performance of the three antibody types in the analysis of thiabendazole, 
imazalil, or tetraconazole in orange and apple juices was investigated. Immunoassays 
are not completely free from interferences caused by unidentified compounds of the 
food matrix. Therefore, it is advisable to determine the importance of these so-called 
matrix effects prior to the recovery test. Accordingly, the influence of orange and apple 
juices on the thiabendazole, imazalil, and tetraconazole ELISA performance was tested 
by obtaining standard curves in the presence of a variable proportion of each juice. 
Results proved that thiabendazole, imazalil, and tetraconazole could be analyzed in 
juices simply by appropriately diluting samples in PBS (data not shown). Thus, 
thiabendazole could be analyzed in orange and apple juices just by diluting samples 
1/10 and 1/100 in PBS, respectively, in monoclonal and recombinant antibody based 
ELISAs. On the other hand, imazalil could be analyzed in orange and apple juices by 
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diluting samples 1/50 and 1/100, respectively, in MAb-based ELISA and by diluting 
both juice samples 1/100 in RAb-based ELISAs. Finally, tetraconazole could be 
analyzed in these juice samples by diluting both juices 1/50 in both types of ELISA. 
Apple and orange juices were spiked with imazalil or tetraconazole at 1000, 2000, 
and 5000 ng/ml or with thiabendazole at 50, 100, and 1000 ng/ml. Samples were 
adequately diluted to enter the respective working range and directly analyzed by 
ELISA. Juice samples without analyte (non-spiked samples) were also included in the 
analysis as negative controls. No false positive results were obtained. Table 4 shows the 
reproducibility and recovery values obtained by ELISA for each juice, analyte and 
antibody type. Reproducibility of both monoclonal and recombinant imazalil ELISAs 
was acceptable. The highest coefficients of variation observed at 1000 ng/ml 
corresponded to the determination near the quantification limit. Overall, recoveries were 
also quite acceptable, although there was a tendency of both recombinant antibody-
based ELISAs to overestimate. The tetraconazole analytical data obtained for both fruit 
juices can be considered as fairly good. In this case, both recombinant antibody ELISAs 
presented a similar behaviour. With regard to thiabendazole ELISAs, the analytical data 
obtained for both fruit juices can be also considered as good enough. Recombinant and 
monoclonal antibody-based ELISAs presented similar behaviour, all of them showing a 
tendency to analyte overestimation in the apple samples. 
In this study the functionality and usefulness of recombinant antibodies as 
analytical tools for the detection of low molecular weight contaminants in food samples 
have been proved. Future work will include RAb purification and stability studies, as 
well as scFv engineering to modify their analytical properties at convenience.   
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Conclusions 
 
RAbs against three fungicides have been produced by cloning and expression of 
hybridoma antibody variable regions. RAb-based immunoassays showed higher analyte 
limits of detection than those based on the parental MAbs. On the other hand, similar 
analytical parameters were estimated for the two types of RAbs under study, scFv 
fragments and scFv-pIII fusion fragments.  
Analysis of spiked fruit juices revealed that comparable recoveries and coefficient 
of variations were obtained by using either RAb or MAb-based immunoassays in their 
respective measuring range. 
RAbs can be obtained in a more cost-effective manner than MAbs because the 
recombinant production in bacteria requires simple inexpensive media for rapid growth 
and it can easily be scaled-up. Moreover, RAb binding characteristics could be modified 
as required by diverse antibody engineering techniques. Therefore, RAb-based 
immunoassays can become a very valuable immunoanalytical tools for the rapid 
screening of fungicide residues in fruit juices.  
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Figure legends 
Figure 1. Competitive curves of monoclonal (●), scFv (▲) and scFv-pIII (■) antibodies for 
imazalil, tetraconazole, and thiabendazole in the conjugate-coated ELISA format. 
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Figure 1 Competitive curves of monoclonal (●), scFv (▲) and scFv-pIII (■) antibodies for imazalil, tetraconazole, 
and thiabendazole in a conjugate-coated ELISA format. 
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 Table 1 Summary of the Analytical Characteristics of Imazalil, Tetraconazole, and 
Thiabendazole Immunoassays Developed with RAbs and MAb
a
 
Fungicide Antibody 
I50 
(ng/mL) 
Working 
range 
(ng/mL) 
LOD 
(ng/mL) 
Imazalil MAb IMH.51 0.8 0.26−2.4 0.1 
 RAb IMH.51 35.0 21.0−59.0 15.0 
 RAb IMH.51-pIII 9.6 5.0−19.0 3.4 
     
Tetraconazole MAb DTPH.41 0.5 0.2−1.4 0.1 
 RAb DTPH.41 8.5 4.0−18.5 2.0 
 RAb DTPH.41-pIII 8.6 3.5−20.0 2.0 
     
Thiabendazole MAb TN3C.33 0.14 0.07−0.5 0.02 
 RAb TN3C.33 0.44 0.2−1.0 0.1 
 RAb TN3C.33-pIII 0.35 0.1−0.9 0.06 
a
 Data are the average of 4 independent standard curves 
Table
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 Table 2 Recognition of Structurally Related Compounds by Thiabendazole  
Antibodies 
  Cross-reactivity
a
 (%) 
Chemical structure Compound 
MAb 
TN3C.33 
RAb 
TN3C.33 
RAb  
TN3C.33-pIII 
N
N
N
S
 
Thiabendazole 100 100 100 
N
N
N
C
OH3C
O
H
 
Carbendazim < 0.1 < 0.1 < 0.1 
N
N
N
C
OH3C
O
H
C
NH3CH2CH2CH2C
H
O
 
Benomyl < 0.1 < 0.1 < 0.1 
N
N
Cl
 
Chlorfenazole 2 5 4 
N
N
O  
Fuberidazole 4 11 8 
N
N
N
N
H3C
CH3
 
Rabenzazole 0.1 0.4 0.3 
a
 Cross-reactivity was calculated as (I50 thiabendazole/I50 compound) x 100 
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 Table 3 Recognition of Structurally Related Compounds by Tetraconazole Antibodies 
  Cross-reactivity
a
 (%) 
Chemical structure Compound 
MAb 
DTPH.41 
RAb 
DTPH.41 
RAb  
DTPH.41-pIII 
N
N
N CH2 CH
Cl
Cl
CH2OCF2CHF2
 
Tetraconazole 100 100 100 
N
N
N CH2 CH
Cl
Cl
CH2CH2CH3
 
Penconazole 44 87 90 
N
N
N CH2 C
Cl
OH
CH2CH2CH2CH3
Cl
 
Hexaconazole < 0.1 0.5 0.7 
N
N
N CH2 CH
Cl
CH2 OH
Cl
 
DTP 24 58 50 
N
N
N CH2 C CHCH3
Cl
OH
 
Cyproconazole 32 63 50 
N
N
N CH2 C CH2CH2CH2CH3
Cl
C
N
 
Myclobutanil 14 33 26 
N
N
N CH O Cl
C O
C(CH3)3
 
Triadimefon 1 1 1 
a
 Cross-reactivity was calculated as (I50 tetraconazole/I50 compound) x 100 
Table
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Table 4 Analysis of Apple (A) and Orange (O) Juices Spiked with Imazalil, Tetraconazole, or Thiabendazole by Monoclonal- and Recombinant- 
Based ELISAs 
 Imazalil  Tetraconazole  Thiabendazole 
 
Spiked level 
(ng/mL)a 
Mean value 
found (ng/mL)b 
CV 
(%) 
Recovery 
(%) 
 
Spiked level 
(ng/mL)c 
Mean value 
found (ng/mL)b 
CV 
(%) 
Recovery 
(%) 
 
Spiked level 
(ng/mL)d 
Mean value 
found (ng/mL)b 
CV 
(%) 
Recovery 
(%) 
MAb A-1000 1360 44 136 A-1000 1190 18 119 A-50 86 16 172 
 A-2000 2120 11 106 A-2000 1680 10 84 A-100 145 17 145 
 A-5000 3950 18 79 A-5000 3900 14 78 A-1000 1290 14 129 
 O-1000 1350 23 135 O-1000 1210 14 121 O-50 44 4 88 
 O-2000 2100 22 105 O-2000 1880 3 94 O-100 101 12 101 
 O-5000 4200 18 84 O-5000 5000 8 100 O-1000 1180 11 118 
RAb A-1000 - e - - A-1000 1090 7 109 A-50 50 9 100 
 A-2000 - - - A-2000 2120 5 106 A-100 135 20 135 
 A-5000 7600 18 152 A-5000 4401 13 88 A-1000 1060 9 106 
 O-1000 - - - O-1000 1320 10 132 O-50 41 19 82 
 O-2000 - - - O-2000 2320 7 116 O-100 110 5 110 
 O-5000 7800 11 156 O-5000 5300 19 106 O-1000 1030 4 103 
RAb-pIII A-1000 1110 44 111 A-1000 1170 1 117 A-50 71 8 142 
 A-2000 2340 14 117 A-2000 2160 12 108 A-100 135 11 135 
 A-5000 5950 17 119 A-5000 4750 7 95 A-1000 1220 7 122 
 O-1000 1250 17 125 O-1000 1450 15 145 O-50 50 5 100 
 O-2000 3000 7 150 O-2000 2640 8 132 O-100 133 8 133 
 O-5000 7500 17 150 O-5000 6400 6 128 O-1000 1120 5 112 
a Imazalil spiked samples at 1000, 2000, and 5000 ng/mL were diluted 1/1000, 1/1000, and 1/2000, respectively, for the MAb-based ELISA; diluted 1/100 for the RAb-based ELISA; and diluted 1/300 
for the RAb-pIII-based ELISA. b Data are the average of four independent determinations. c Tetraconazole spiked samples at 1000, 2000, and 5000 ng/mL were diluted 1/500, 1/1000, and 1/2500, 
respectively, for the MAb-based ELISA, and diluted 1/100, 1/100, and 1/500, respectively, for the RAb-based ELISAs. d Thiabendazole spiked samples at 50, 100, and 1000 ng/ml were diluted 1/100, 
1/100, and 1/1000, respectively, for MAb- and RAb-based ELISAs. e Samples below the ELISA detection limit.  
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